Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders

@article{Raikwar2019NextGP,
  title={Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders},
  author={Sudhanshu P. Raikwar and Nidhi S Kikkeri and Ragha Chaitanya Sakuru and Daniyal Saeed and Haris Zahoor and Keerthivaas Premkumar and Shireen Mentor and Ramasamy Thangavel and Iuliia Dubova and Mohammad Ejaz Ahmed and Govindhasamy Pushpavathi Selvakumar and Duraisamy Kempuraj and Smita A Zaheer and Shankar Subramanian Iyer and Asgar Zaheer},
  journal={Journal of Neuroimmune Pharmacology},
  year={2019},
  pages={1-34}
}
AbstractDespite significant advancements in the field of molecular neurobiology especially neuroinflammation and neurodegeneration, the highly complex molecular mechanisms underlying neurodegenerative diseases remain elusive. As a result, the development of the next generation neurotherapeutics has experienced a considerable lag phase. Recent advancements in the field of genome editing offer a new template for dissecting the precise molecular pathways underlying the complex neurodegenerative… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 305 REFERENCES

Rapidly evolving homing CRISPR barcodes

VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

2018a) Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

JH Hu, SM Miller, +8 authors DR Liu
  • Nature
  • 2018
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Engineering of CRISPR-Cas12b for human genome editing

  • Nature Communications
  • 2018
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

RNA targeting with CRISPR–Cas13

VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…